Acuta Capital Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
2020
Q3
$2.27M Sell
2020
Q2
$9.05M Buy
2020
Q1
$500K Sell
2019
Q4
$9.75M Buy
2019
Q2
Sell
2019
Q1
$204K Hold
2018
Q4
$202K Buy
2018
Q1
Sell
2017
Q4
$4.42M Sell
2017
Q3
$5.22M Buy
2017
Q2
$938K Sell
2017
Q1
$7.73M Buy
2016
Q4
$950K Sell
2016
Q3
$2.44M Buy
2015
Q4
Sell
2015
Q3
$3.09M Buy